相关实验视频
Updated: Jan 16, 2026

10:23
Evaluation of Caspase Activation to Assess Innate Immune Cell Death
Published on: January 20, 2023
3.8K
埃梅斯特林类型的epidithiodiketopiperazines通过卡斯帕斯-3/7激活抑制了D介导的气体皮质死
Bingchuan Geng1,2,3,4, Shuang Lin1,5, Wai Yen Yim4
1Hubei Key Laboratory of Natural Medicinal Chemistry and Resource Evaluation, School of Pharmacy Tongji Medical College, Huazhong University of Science and Technology Wuhan China.
MedComm
|January 15, 2026
概括
埃梅斯林类型的epidithiodiketopiperazines (ETPs) 抑制了Gasdermin D (GSDMD) 的裂变,减少了热和炎症. 化合物2在败血症模型中显示出治疗潜力,改善生存率和抑制炎症细胞透.
科学领域:
- 生物化学 生物化学
- 免疫学 免疫学 免疫学
- 药理学 药理学是指药理学的学科.
背景情况:
- 败血症涉及到对感染的失调宿主反应,通常由炎症性细胞死亡途径 - - 炎症性细胞死亡途径 - - 恶化.
- 加斯德明D (GSDMD) 的激活是热的核心,导致毛孔形成和炎症.
研究的目的:
- 为了识别GSDMD裂变在烧灭过程中的抑制剂.
- 在败血症模型中评估埃梅斯林类型的epidithiodiketopiperazines (ETPs) 的治疗潜力.
主要方法:
- 高通量查确定了ETP作为GSDMD裂变抑制剂.
- 表面等离子体共振和西部涂抹证实ETPs激活caspase-3/7,分裂GSDMD.
- 在体内研究中使用了脂聚糖 (LPS) 诱导的冲击和结和穿孔 (CLP) 模型.
- 单细胞RNA测序 (scRNA-seq) 分析了小鼠肺组织的反应.
主要成果:
- 已确定ETPs是GSDMD裂变的强有力的抑制剂,可以防止热.
- ETPs激活caspase-3/7,导致GSDMD在Asp87裂变,产生p10片段并抑制孔隙形成.
- 化合物2是一种ETP,可以防止致命的LPS诱导的败血症休克和减少肺炎.
- 在CLP模型中,化合物2通过减少GSDMD阳性中性粒细胞和单细胞透,显著改善了生存率.
- scRNA-seq揭示化合物2通过抑制单细胞衍生树突细胞 (moDC) 成熟来抑制LPS诱导的炎症.
结论:
- ETPs有效地向GSDMD驱动的热,为败血症提供了一种新的治疗策略.
- 化合物2通过减轻炎症和改善生存率,在治疗败血症的临床转化方面显示出显著的希望.
相关概念视频
Caspases
13.7K
Caspase, a family of cysteine proteases, serve as effectors in apoptosis. The ced3 gene in C.elegans was first identified to be involved in apoptosis. This gene encodes the ced-3 caspase that is similar to the interleukin-1-beta converting enzyme or ICE in mammals. In addition to apoptosis, caspases also function in the inflammatory response. Inflammatory caspases are essential in activating pro-inflammatory cytokines that recruit immune cells and block the replication of pathogens inside...
13.7K
The Extrinsic Apoptotic Pathway
8.1K
The extrinsic apoptotic pathway is initiated when extracellular death-inducing signals, such as specific cytokines, activate the death receptors expressed on the cell surface. The immune cells involved in this pathway are natural killer cells (NK cells) and cytotoxic T-lymphocytes. NK cells are critical in innate immune response, while cytotoxic T-lymphocytes are associated with adaptive immune response. These cells recognize specific receptors expressed on the altered cells and activate...
8.1K
Drugs for Peptic Ulcer Disease: Prostaglandin Analogs as Mucosal Protective Agents
1.1K
The gastric mucosa produces prostaglandins E2 (PGE2) and prostacyclin (PGI2), crucial in maintaining gastric health. They exert cytoprotective effects, including increasing bicarbonate secretion, releasing protective mucin, reducing gastric acid output, and preventing harmful vasoconstriction. These effects are mediated through various receptors, such as EP1, EP2, EP3, and EP4.
Non-steroidal anti-inflammatory drugs (NSAIDs) can induce peptic ulcers by inhibiting cyclooxygenase, decreasing...
Non-steroidal anti-inflammatory drugs (NSAIDs) can induce peptic ulcers by inhibiting cyclooxygenase, decreasing...
1.1K
IP3/DAG Signaling Pathway
14.3K
Membrane lipids such as phosphatidylinositol (PI) are precursors for several membrane-bound and soluble second messengers. Specific kinases phosphorylate PI and produce phosphorylated inositol phospholipids. One such inositol phospholipids are the phosphatidylinositol-4,5 bisphosphate [PI(4,5)P2], present in the inner half of the lipid bilayer. Upon ligand binding, GPCR stimulates Gq proteins to turn on phospholipase Cꞵ. Activated phospholipase Cꞵ cleaves PI(4,5)P2 and...
14.3K
The Intrinsic Apoptotic Pathway
8.3K
Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
8.3K
Treatment for Pulmonary Arterial Hypertension: Endothelin Receptor Antagonists
440
Endothelins (ETs) are potent vasoactive peptides critical in the human body's various physiological and pathological processes. One of the most promising therapeutic strategies for treating pulmonary arterial hypertension (PAH) involves counteracting the effects of these endothelins using a class of drugs known as endothelin receptor antagonists.
ETs are synthesized through a complex sequence of enzymatic steps, primarily involving an enzyme referred to as endothelin-converting enzyme...
ETs are synthesized through a complex sequence of enzymatic steps, primarily involving an enzyme referred to as endothelin-converting enzyme...
440

